Concepedia

Katsuhiko Hagi

KH

Statistics

Publications

8

Citations

800

H-Index

8

Active since

1993

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

Japan Coal Energy Center

Kyoto University

Chiba University

Tokyo Institute of Psychiatry

Katsuhiko Hagi is an author at Sumitomo Dainippon Pharma (Japan) specializing in macrophage biology, innate immunity, and pharmacology.

ORCID

Publications per year

1993–2020

8

Publications

8

Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow.

K Inaba, Muneo Inaba, Masashi Deguchi et al. · Proceedings of the National Academy of Sciences · 1993 · 423 citations

, , +14

Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta‐analysis and meta‐regression analysis

Britta Galling, Alexandra Roldán, Katsuhiko Hagi et al. · World Psychiatry · 2017 · 236 citations · Full text

, , +17

Augmenting effect of opioid peptides on murine macrophage activation

Katsuhiko Hagi, Kazuko Uno, Kayo Inaba · Journal of Neuroimmunology · 1994 · 53 citations

, , +10

Lurasidone in the treatment of schizophrenia: Results of a double‐blind, placebo‐controlled trial in Asian patients

Teruhiko Higuchi, Jun Ishigooka, Masaomi Iyo et al. · Asia-Pacific Psychiatry · 2019 · 36 citations

, , +15

Enhancement of murine bone marrow macrophage differentiation by beta- endorphin

Katsuhiko Hagi, Kensuke Inaba, Hiraki Sakuta et al. · Blood · 1995 · 20 citations · Full text

, , +13

1–5 of 8